Lijun International Pharmaceutical (Holding) Co., Limited () () is a

Wanchai Wan Chai is situated at the western part of the Wan Chai District on the northern shore of Hong Kong Island, in Hong Kong. Its other boundaries are Canal Road to the east, Arsenal Street to the west and Bowen Road to the south. The area no ...

Hong Kong Hong Kong ( (US) or (UK); , ), officially the Hong Kong Special Administrative Region of the People's Republic of China (abbr. Hong Kong SAR or HKSAR), is a city and special administrative region of China on the eastern Pearl River Delta i ...

-based investment

holding company A holding company is a company whose primary business is holding a controlling interest in the securities of other companies. A holding company usually does not produce goods or services itself. Its purpose is to own shares of other companies ...

with two pharmaceutical business segments:

Business segments

* manufacturing and selling of intravenous infusion solution * manufacturing and selling of

antibiotics An antibiotic is a type of antimicrobial substance active against bacteria. It is the most important type of antibacterial agent for fighting bacterial infections, and antibiotic medications are widely used in the treatment and prevention o ...

and others The Group was listed on Hong Kong Stock Exchange in December 2005 (stock code: 2005). The Group is engaged in the research, development, manufacturing and selling of a wide range of finished medicines and bulk pharmaceutical products to hospitals and distributors, including antibiotics, intravenous infusion solution, non-antibiotics finished products, bulk pharmaceuticals and health care product.

Subsidiaries

The Company’s subsidiaries include: * New Orient Limited (New Orient) in Hong Kong * Shijiazhuang No. 4 Pharmaceutical Co., Limited, intravenous infusion solution manufacturer in

Hebei Province Hebei or , (; alternately Hopeh) is a northern province of China. Hebei is China's sixth most populous province, with over 75 million people. Shijiazhuang is the capital city. The province is 96% Han Chinese, 3% Manchu, 0.8% Hui, and 0 ...

(acquired in June 2007) * Xi’an Lijun Pharmaceutical Co., Limited (Xi’an Lijun), engaged in manufacturing pharmaceuticals in

Shaanxi Province Shaanxi (alternatively Shensi, see § Name) is a landlocked province of China. Officially part of Northwest China, it borders the province-level divisions of Shanxi (NE, E), Henan (E), Hubei (SE), Chongqing (S), Sichuan (SW), Gansu (W), Ni ...

* Shenzhen Lijun Pharmaceutical Co., Limited, engaged in manufacturing pharmaceuticals in Guangdong Province. The Company is the largest domestic manufacturer of

macrolide The Macrolides are a class of natural products that consist of a large macrocyclic lactone ring to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. The lactone rings are usually 14-, 15-, or 16-membered. Ma ...

antibiotics, with a leading position for its intravenous infusion solution products in high-end hospital market. Facing more

merger and acquisition Mergers and acquisitions (M&A) are business transactions in which the ownership of companies, other business organizations, or their operating units are transferred to or consolidated with another company or business organization. As an aspec ...

opportunities from medical reform in China, the Group is positioned for continuous mergers and acquisitions to promote its growth.

External links

Lijun (Official website)
{{Pharmaceutical companies of China Pharmaceutical companies of Hong Kong Companies listed on the Hong Kong Stock Exchange Holding companies established in 2004 Pharmaceutical companies established in 2004